Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities. The Company is engaged in operating acute inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers and facilities providing outpatient behavioral healthcare services. As of December 31, 2016, the U.S. Facilities segment included 208 behavioral healthcare facilities with approximately 8,500 beds in 39 states and Puerto Rico, and the U.K. Facilities segment included 365 behavioral healthcare facilities with approximately 8,600 beds in the United Kingdom. As of December 31, 2016, the Company had operated 573 behavioral healthcare facilities with approximately 17,100 beds in 39 states, the United Kingdom and Puerto Rico.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Healthcare Facilities & Services - NEC
- Sub-Industry: Health Care Facilities
- Symbol: NASDAQ:ACHC
- CUSIP: 00404A10
- Web: www.acadiahealthcare.com
Capitalization:- Market Cap: $4.33 billion
- Outstanding Shares: 87,817,000
Average Prices:- 50 Day Moving Avg: $47.66
- 200 Day Moving Avg: $43.41
- 52 Week Range: $32.54 - $57.29
P/E:- Trailing P/E Ratio: 286.92
- Foreward P/E Ratio: 17.47
- P/E Growth: 1.54
Sales & Book Value:- Annual Revenue: $2.87 billion
- Price / Sales: 1.51
- Book Value: $25.73 per share
- Price / Book: 1.91
Profitability:- EBIDTA: $585.16 million
- Net Margins: 0.53%
- Return on Equity: 8.89%
- Return on Assets: 3.20%
Debt:- Debt-to-Equity Ratio: 1.45%
- Current Ratio: 1.26%
- Quick Ratio: 1.26%
Misc:- Average Volume: 1.08 million shs.
- Beta: 1.14
- Short Ratio: 24.79
Frequently Asked Questions for Acadia Healthcare Company (NASDAQ:ACHC)
What is Acadia Healthcare Company's stock symbol?
Acadia Healthcare Company trades on the NASDAQ under the ticker symbol "ACHC."
How were Acadia Healthcare Company's earnings last quarter?
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) released its quarterly earnings data on Friday, July, 29th. The company reported $0.73 EPS for the quarter, hitting the Thomson Reuters' consensus estimate of $0.73. The business had revenue of $756.50 million for the quarter, compared to analyst estimates of $752.57 million. Acadia Healthcare Company had a return on equity of 8.89% and a net margin of 0.53%. The business's quarterly revenue was up 66.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.57 EPS. View Acadia Healthcare Company's Earnings History.
When will Acadia Healthcare Company make its next earnings announcement?
Where is Acadia Healthcare Company's stock going? Where will Acadia Healthcare Company's stock price be in 2017?
12 brokers have issued 12 month price targets for Acadia Healthcare Company's shares. Their predictions range from $45.00 to $80.00. On average, they expect Acadia Healthcare Company's stock price to reach $57.82 in the next twelve months. View Analyst Ratings for Acadia Healthcare Company.
What are analysts saying about Acadia Healthcare Company stock?
Here are some recent quotes from research analysts about Acadia Healthcare Company stock:
- 1. According to Zacks Investment Research, "Acadia Healthcare is well positioned for long term growth on the back of its inorganic strategies. The latest Priory acquisition has substantially enhanced its asset base as the largest independent provider of mental health services in the U.K. Its mixed product portfolio has helped in diversifying the business risk. Year to date, the shares of Acadia Healthcare have outperformed the Zacks Hospitals industry. But the company suffers from high debt, escalating interest expenses and foreign exchange fluctuation. It is also exposed to foreign currency fluctuation. Substantial integration risks associated with its frequent acquisitions also remain a major headwind." (6/28/2017)
- 2. Cantor Fitzgerald analysts commented, "ACHC’s weak 1Q17 organic growth and a slight revenue and adjusted EBITDA miss are measured against tough comps, which continue in 2Q17, but ease in the second half, assuming no further decline in the pound. Volumes, up 5.8%, were okay in the U.S., but essentially flat overseas, and 2Q16, when organic growth was also strong, could be a tough comparison." (4/26/2017)
Who are some of Acadia Healthcare Company's key competitors?
Some companies that are related to Acadia Healthcare Company include Mednax (MD), NMC Health PLC (NMC), Molina Healthcare (MOH), HealthSouth Corporation (HLS), Chemed Corp. (CHE), LifePoint Health (LPNT), Select Medical Holdings Corporation (SEM), Udg Healthcare PLC (UDG), Tenet Healthcare Corporation (THC), HMS Holdings Corp (HMSY), Community Health Systems (CYH), Kindred Healthcare (KND), China Cord Blood Corporation (CO), HealthStream (HSTM), American Renal Associates Holdings (ARA), Georgia Healthcare Group PLC (GHG), Cambian Group PLC (CMBN) and Concord Medical Services Holdings Limited (CCM).
Who are Acadia Healthcare Company's key executives?
Acadia Healthcare Company's management team includes the folowing people:
- Joey A. Jacobs, Chairman of the Board, Chief Executive Officer
- W. Brent Turner, President
- Bruce A. Shear, Executive Vice Chairman
- David M. Duckworth, Chief Financial Officer
- Ronald Morgan Fincher, Chief Operating Officer
- Christopher L. Howard, Executive Vice President, General Counsel, Secretary
- Reeve B. Waud Jr., Lead Independent Director
- E. Perot Bissell, Independent Director
- Christopher R. Gordon, Independent Director
- Vicky B. Gregg, Independent Director
Who owns Acadia Healthcare Company stock?
Acadia Healthcare Company's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include GW&K Investment Management LLC (0.50%), Pembroke Management LTD (0.45%), Russell Investments Group Ltd. (0.30%), Peregrine Capital Management LLC (0.26%), Berson & Corrado Investment Advisors LLC (0.10%) and Bank of Montreal Can (0.06%). Company insiders that own Acadia Healthcare Company stock include Bain Capital Investors Llc, Danny E Carpenter, David M Duckworth, Randall P Goldberg, Reeve B Waud, Ronald Morgan Fincher, Waud Capital Partners Ii, LL, Waud Capital Partners Iii, LL and William Grieco. View Institutional Ownership Trends for Acadia Healthcare Company.
Who sold Acadia Healthcare Company stock? Who is selling Acadia Healthcare Company stock?
Acadia Healthcare Company's stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can. Company insiders that have sold Acadia Healthcare Company stock in the last year include David M Duckworth, Randall P Goldberg, Reeve B Waud, Ronald Morgan Fincher, Waud Capital Partners Ii, LL, Waud Capital Partners Iii, LL and William Grieco. View Insider Buying and Selling for Acadia Healthcare Company.
Who bought Acadia Healthcare Company stock? Who is buying Acadia Healthcare Company stock?
Acadia Healthcare Company's stock was acquired by a variety of institutional investors in the last quarter, including GW&K Investment Management LLC, Russell Investments Group Ltd., State Treasurer State of Michigan, Oregon Public Employees Retirement Fund, Louisiana State Employees Retirement System, ING Groep NV, NN Investment Partners Holdings N.V. and Capstone Asset Management Co.. View Insider Buying and Selling for Acadia Healthcare Company.
How do I buy Acadia Healthcare Company stock?
Shares of Acadia Healthcare Company can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Acadia Healthcare Company's stock price today?
One share of Acadia Healthcare Company stock can currently be purchased for approximately $49.26.
MarketBeat Community Rating for Acadia Healthcare Company (NASDAQ ACHC)MarketBeat's community ratings are surveys of what our community members think about Acadia Healthcare Company and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Acadia Healthcare Company (NASDAQ:ACHC) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 3 Hold Ratings, 8 Buy Ratings, 1 Strong Buy Rating |
| Consensus Rating: | Buy (Score: 2.83) |
| Consensus Price Target: | $57.82 (17.37% upside) |
Analysts' Ratings History for Acadia Healthcare Company (NASDAQ:ACHC)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 7/18/2017 | William Blair | Initiated Coverage | Outperform -> Outperform | | Low |  |
| 6/1/2017 | KeyCorp | Reiterated Rating | Overweight | $51.00 | Low | |
| 6/1/2017 | Jefferies Group LLC | Set Price Target | Buy | $55.00 | Low | |
| 5/15/2017 | Leerink Swann | Downgrade | Outperform -> Market Perform | | Medium | |
| 4/26/2017 | Cantor Fitzgerald | Reiterated Rating | Hold | $45.00 | High | |
| 4/5/2017 | Deutsche Bank AG | Initiated Coverage | Buy -> Buy | $53.00 | High | |
| 3/6/2017 | Citigroup Inc. | Boost Price Target | Buy | $43.00 -> $52.00 | N/A | |
| 2/27/2017 | Mizuho | Reiterated Rating | Buy -> Buy | $45.00 -> $52.00 | N/A | |
| 1/3/2017 | Royal Bank Of Canada | Reiterated Rating | Buy | $56.00 | N/A | |
| 11/3/2016 | Raymond James Financial, Inc. | Upgrade | Outperform -> Strong-Buy | $65.00 | N/A | |
| 9/27/2016 | J P Morgan Chase & Co | Reiterated Rating | Hold | $61.00 | N/A | |
| 9/15/2016 | Robert W. Baird | Lower Price Target | Outperform | $67.00 -> $66.00 | N/A | |
| 2/20/2016 | Stephens | Reiterated Rating | Buy | | N/A | |
| 2/18/2016 | Susquehanna Bancshares Inc | Lower Price Target | Positive | $92.00 -> $75.00 | N/A | |
| 2/18/2016 | Craig Hallum | Lower Price Target | Buy | $100.00 -> $85.00 | N/A | |
| 2/17/2016 | Avondale Partners | Lower Price Target | Market Outperform | $90.00 -> $71.00 | N/A | |
(Data available from 7/26/2015 forward)
Earnings History for Acadia Healthcare Company (NASDAQ:ACHC)Earnings History by Quarter for Acadia Healthcare Company (NASDAQ ACHC)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 7/27/2017 | | $0.65 | | | | | N/A | |
| 4/25/2017 | Q1 2017 | $0.46 | $0.46 | $691.74 million | $679.20 million | View | N/A | |
| 2/23/2017 | Q416 | $0.55 | $0.59 | $708.41 million | $702.89 million | View | Listen | |
| 11/1/2016 | Q3 | $0.59 | $0.58 | $735.59 million | $789.40 million | View | Listen | |
| 7/29/2016 | Q216 | $0.73 | $0.73 | $752.57 million | $756.50 million | View | Listen | |
| 4/28/2016 | Q1 | $0.54 | $0.55 | $612.77 million | $616.80 million | View | Listen | |
| 2/16/2016 | Q4 | $0.59 | $0.59 | $488.00 million | $495.30 million | View | Listen | |
| 11/3/2015 | Q315 | $0.57 | $0.62 | $7.63 million | $479.70 million | View | Listen | |
| 8/4/2015 | Q215 | $0.52 | $0.57 | $433.84 million | $453.70 million | View | Listen | |
| 4/28/2015 | Q115 | $0.41 | $0.43 | $356.21 million | $365.80 million | View | Listen | |
| 2/11/2015 | Q414 | $0.46 | $0.46 | $296.20 million | $294.90 million | View | Listen | |
| 10/29/2014 | Q214 | $0.41 | $0.46 | $284.31 million | $294.50 million | View | Listen | |
| 7/29/2014 | Q114 | $0.31 | $0.58 | $207.73 million | $213.80 million | View | Listen | |
| 4/29/2014 | Q413 | $0.28 | $0.28 | $194.83 million | $206.10 million | View | Listen | |
| 2/28/2014 | Q313 | $0.29 | $0.29 | $189.56 million | $190.00 million | View | Listen | |
| 10/30/2013 | | $0.27 | $0.29 | $179.47 million | $184.70 million | View | Listen | |
| 7/30/2013 | Q2 2013 | $0.25 | $0.26 | $169.21 million | $177.50 million | View | Listen | |
| 11/6/2012 | Q312 | $0.16 | $0.16 | $104.91 million | $103.10 million | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Acadia Healthcare Company (NASDAQ:ACHC)2017 EPS Consensus Estimate: $2.46
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 3 | $0.45 | $0.48 | $0.47 |
| Q2 2017 | 5 | $0.64 | $0.67 | $0.66 |
| Q3 2017 | 5 | $0.64 | $0.68 | $0.66 |
| Q4 2017 | 4 | $0.66 | $0.71 | $0.68 |
(Data provided by Zacks Investment Research)
Dividend History for Acadia Healthcare Company (NASDAQ:ACHC)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Acadia Healthcare Company (NASDAQ:ACHC)Insider Ownership Percentage: 11.10%
Insider Trades by Quarter for Acadia Healthcare Company (NASDAQ:ACHC)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 7/5/2017 | Reeve B. Waud | Director | Sell | 50,000 | $50.04 | $2,502,000.00 | |
| 6/22/2017 | Reeve B. Waud | Director | Sell | 50,000 | $47.51 | $2,375,500.00 | |
| 6/16/2017 | William Grieco | Director | Sell | 2,000 | $45.42 | $90,840.00 | |
| 6/14/2017 | Reeve B. Waud | Director | Sell | 724,694 | $45.53 | $32,995,317.82 | |
| 6/9/2017 | Reeve B. Waud | Director | Sell | 50,000 | $45.09 | $2,254,500.00 | |
| 5/4/2017 | Randall P Goldberg | VP | Sell | 4,925 | $45.18 | $222,511.50 | |
| 5/1/2017 | Ronald Morgan Fincher | COO | Sell | 86,483 | $44.43 | $3,842,439.69 | |
| 3/8/2017 | Randall P Goldberg | VP | Sell | 914 | $43.55 | $39,804.70 | |
| 12/16/2016 | Reeve B Waud | Director | Sell | 28,000 | $34.58 | $968,240.00 | |
| 12/14/2016 | Reeve B Waud | Director | Sell | 42,000 | $34.71 | $1,457,820.00 | |
| 12/13/2016 | Reeve B Waud | Director | Sell | 14,000 | $35.10 | $491,400.00 | |
| 12/12/2016 | Reeve B Waud | Director | Sell | 14,000 | $35.79 | $501,060.00 | |
| 9/16/2016 | Reeve B Waud | Director | Sell | 1,360,977 | $48.52 | $66,034,604.04 | |
| 9/16/2016 | Waud Capital Partners Iii, L.L | Major Shareholder | Sell | 457,443 | $48.39 | $22,135,666.77 | |
| 9/13/2016 | Reeve B Waud | Director | Sell | 84,208 | $51.71 | $4,354,395.68 | |
| 9/13/2016 | Waud Capital Partners Ii, L.L. | Major Shareholder | Sell | 54,254 | $51.71 | $2,805,474.34 | |
| 8/15/2016 | David M Duckworth | CFO | Sell | 16,670 | $54.33 | $905,681.10 | |
| 8/12/2016 | Ronald Morgan Fincher | COO | Sell | 14,604 | $52.50 | $766,710.00 | |
| 8/8/2016 | Ronald Morgan Fincher | COO | Sell | 8,800 | $52.56 | $462,528.00 | |
| 11/6/2015 | Danny E Carpenter | Major Shareholder | Sell | 15,000 | $74.02 | $1,110,300.00 | |
| 8/14/2015 | Bain Capital Investors Llc | Insider | Sell | 2,351,137 | $80.47 | $189,195,994.39 | |
| 8/14/2015 | Reeve B Waud | Director | Sell | 2,400,001 | $80.47 | $193,128,080.47 | |
| 8/14/2015 | Waud Capital Partners Ii, L.L. | Major Shareholder | Sell | 1,635,457 | $80.47 | $131,605,224.79 | |
| 4/2/2015 | Joey A Jacobs | CEO | Sell | 24,277 | $70.06 | $1,700,846.62 | |
| 3/16/2015 | Robert Walton Swinson | Major Shareholder | Sell | 5,981 | $69.58 | $416,157.98 | |
| 3/13/2015 | Brent Turner | Major Shareholder | Sell | 11,779 | $69.68 | $820,760.72 | |
| 2/19/2015 | David M Duckworth | CFO | Sell | 9,504 | $62.31 | $592,194.24 | |
| 2/19/2015 | Ronald Morgan Fincher | COO | Sell | 10,703 | $62.50 | $668,937.50 | |
| 2/18/2015 | Christopher L Howard | EVP | Sell | 9,378 | $62.75 | $588,469.50 | |
| 12/8/2014 | Robert Walton Swinson | Major Shareholder | Sell | 2,500 | $64.25 | $160,625.00 | |
| 11/6/2014 | Danny E Carpenter | Major Shareholder | Sell | 9,460 | $60.82 | $575,357.20 | |
| 11/3/2014 | Brent Turner | Major Shareholder | Sell | 35,167 | $60.18 | $2,116,350.06 | |
| 11/3/2014 | Bruce A Shear | Chairman | Sell | 25,000 | $59.12 | $1,478,000.00 | |
| 11/3/2014 | Christopher L Howard | EVP | Sell | 29,245 | $59.94 | $1,752,945.30 | |
| 11/3/2014 | Joey A Jacobs | CEO | Sell | 133,087 | $59.95 | $7,978,565.65 | |
| 11/3/2014 | Ronald Morgan Fincher | COO | Sell | 29,695 | $60.42 | $1,794,171.90 | |
| 8/25/2014 | William Grieco | Director | Sell | 4,522 | $50.67 | $229,129.74 | |
| 8/21/2014 | William Grieco | Director | Sell | 7,000 | $50.33 | $352,310.00 | |
| 8/13/2014 | David M Duckworth | CFO | Sell | 1,400 | $48.79 | $68,306.00 | |
| 8/13/2014 | Ronald Morgan Fincher | COO | Sell | 2,489 | $48.00 | $119,472.00 | |
| 7/29/2014 | Christopher L Howard | EVP | Sell | 1,156 | $51.01 | $58,967.56 | |
| 7/29/2014 | Jack E Polson | Major Shareholder | Sell | 4,000 | $50.34 | $201,360.00 | |
| 6/4/2014 | Ronald Morgan Fincher | COO | Sell | 4,442 | $47.68 | $211,794.56 | |
| 5/2/2014 | Brent Turner | major shareholder | Sell | 24,595 | $45.00 | $1,106,775.00 | |
| 5/2/2014 | Christopher Howard | EVP | Sell | 11,536 | $40.76 | $470,207.36 | |
| 5/2/2014 | Joey Jacobs | CEO | Sell | 19,291 | $45.00 | $868,095.00 | |
| 5/1/2014 | Norman King Carter III | major shareholder | Sell | 10,896 | $42.04 | $458,067.84 | |
| 4/29/2014 | Norman King Carter III | major shareholder | Sell | 30,000 | $41.73 | $1,251,900.00 | |
| 4/9/2014 | Karen Marie Prince | major shareholder | Sell | 5,579 | $44.09 | $245,978.11 | |
| 3/14/2014 | Bruce Shear | Chairman | Sell | 38,069 | $46.10 | $1,754,980.90 | |
| 3/14/2014 | David Duckworth | CFO | Sell | 7,540 | $45.73 | $344,804.20 | |
| 3/14/2014 | William Grieco | Director | Sell | 5,000 | $46.29 | $231,450.00 | |
| 2/3/2014 | Norman King Carter III | major shareholder | Sell | 20,000 | $51.08 | $1,021,600.00 | |
| 1/31/2014 | Karen Marie Prince | major shareholder | Sell | 10,000 | $51.42 | $514,200.00 | |
| 1/29/2014 | Norman King Carter III | major shareholder | Sell | 30,000 | $51.79 | $1,553,700.00 | |
| 11/1/2013 | Norman King Carter III | Major Shareholder | Sell | 29,600 | $42.20 | $1,249,120.00 | |
| 10/29/2013 | Karen Marie Prince | Major Shareholder | Sell | 20,000 | $39.14 | $782,800.00 | |
| 8/1/2013 | Karen Marie Prince | Major Shareholder | Sell | 28,000 | $35.80 | $1,002,400.00 | |
| 7/31/2013 | Norman King Carter III | Major Shareholder | Sell | 20,000 | $35.30 | $706,000.00 | |
| 7/29/2013 | Karen Marie Prince | Major Shareholder | Sell | 22,000 | $34.26 | $753,720.00 | |
| 6/10/2013 | William Grieco | Director | Sell | 13,000 | $34.77 | $452,010.00 | |
| 5/15/2013 | Bruce A Shear | Chairman | Sell | 10,000 | $34.50 | $345,000.00 | |
| 5/10/2013 | William Grieco | Director | Sell | 15,000 | $33.34 | $500,100.00 | |
| 5/9/2013 | David M Duckworth | CFO | Sell | 4,000 | $33.20 | $132,800.00 | |
| 5/7/2013 | Ronald Morgan Fincher | COO | Sell | 2,804 | $32.78 | $91,915.12 | |
| 12/24/2012 | Brent Turner | Major Shareholder | Sell | 10,551 | $21.60 | $227,901.60 | |
| 12/24/2012 | Bruce A Shear | Chairman | Sell | 7,500 | $21.60 | $162,000.00 | |
| 12/24/2012 | Christopher L Howard | EVP | Sell | 8,774 | $21.60 | $189,518.40 | |
| 12/24/2012 | Joey A Jacobs | CEO | Sell | 39,927 | $21.60 | $862,423.20 | |
| 12/24/2012 | Reeve B Waud | Director | Sell | 425,591 | $21.60 | $9,192,765.60 | |
| 12/24/2012 | Ronald Morgan Fincher | COO | Sell | 8,909 | $21.60 | $192,434.40 | |
(Data available from 1/1/2013 forward)
Headline Trends for Acadia Healthcare Company (NASDAQ:ACHC)
Latest Headlines for Acadia Healthcare Company (NASDAQ:ACHC)
| Source: |
|
| Date | Headline |
|---|
 | HCA Healthcare (HCA) Q2 Earnings & Revenues Lag, Stock Dips - Nasdaq
www.nasdaq.com - July 25 at 3:17 PM |
 | HCA Healthcare (HCA) Q2 Earnings & Revenues Lag, Stock Dips
finance.yahoo.com - July 25 at 3:17 PM |
 | Mount Carmel picks for-profit joint venture partner to build $26M psychiatric hospital - Columbus Business First
www.bizjournals.com - July 24 at 11:57 PM |
| Mount Carmel picks for-profit joint venture partner to build $26M psychiatric hospital
finance.yahoo.com - July 24 at 6:56 PM |
 | Brokerages Expect Acadia Healthcare Company, Inc. (ACHC) Will Post Quarterly Sales of $717.00 Million
www.americanbankingnews.com - July 21 at 8:00 PM |
| Centene & Unit Inks New Deal to Expand Foothold in Ferguson
finance.yahoo.com - July 20 at 3:27 PM |
| Acadia Healthcare Company, Inc. Expected to Post Q2 2017 Earnings of $0.64 Per Share (NASDAQ:ACHC)
www.americanbankingnews.com - July 20 at 8:16 AM |
| Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Scheduled to Post Quarterly Earnings on Thursday
www.americanbankingnews.com - July 20 at 7:02 AM |
| Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Director Reeve B. Waud Sells 50,000 Shares
www.americanbankingnews.com - July 6 at 7:22 PM |
 | Acadia Healthcare Announces Date for Second Quarter 2017 Earnings Release - GlobeNewswire (press release)
globenewswire.com - July 6 at 4:48 PM |
| Acadia Healthcare Announces Date for Second Quarter 2017 Earnings Release
finance.yahoo.com - July 6 at 4:47 PM |
| Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - July 4 at 10:34 AM |
| Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Upgraded by Zacks Investment Research to "Buy"
www.americanbankingnews.com - July 2 at 12:02 PM |
| Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Upgraded to Buy by BidaskClub
www.americanbankingnews.com - July 1 at 7:32 PM |
| Research Analysts Issue Forecasts for Acadia Healthcare Company, Inc.'s FY2018 Earnings (ACHC)
www.americanbankingnews.com - June 26 at 11:28 AM |
| Zacks: Brokerages Anticipate Acadia Healthcare Company, Inc. (ACHC) Will Announce Quarterly Sales of $717.26 Million
www.americanbankingnews.com - June 24 at 7:38 AM |
| Acadia Healthcare Company, Inc. (ACHC) Director Reeve B. Waud Sells 50,000 Shares
www.americanbankingnews.com - June 23 at 7:14 PM |
| Acadia Healthcare Company, Inc. (ACHC) Expected to Post Earnings of $0.65 Per Share
www.americanbankingnews.com - June 23 at 12:12 AM |
 | Stock Performance Review on Specialized Health Services Industry -- Acadia Healthcare, DaVita, HealthSouth, and MEDNAX
www.marketwatch.com - June 22 at 1:06 PM |
| Acadia Healthcare Company, Inc. (ACHC) Director William Grieco Sells 2,000 Shares
www.americanbankingnews.com - June 19 at 7:56 PM |
| Can Acadia Be a Solid Choice for Value Investors?
finance.yahoo.com - June 19 at 3:20 PM |
| Head to Head Contrast: AMN Healthcare Services (AMN) vs. Acadia Healthcare Company (ACHC)
www.americanbankingnews.com - June 17 at 2:08 PM |
| Reeve B. Waud Sells 724,694 Shares of Acadia Healthcare Company, Inc. (ACHC) Stock
www.americanbankingnews.com - June 15 at 7:23 PM |
| ETFs with exposure to Acadia Healthcare Co., Inc. : June 15, 2017
finance.yahoo.com - June 15 at 3:26 PM |
| Insider Selling: Acadia Healthcare Company, Inc. (ACHC) Director Sells 50,000 Shares of Stock
www.americanbankingnews.com - June 13 at 7:50 AM |
| Acadia Healthcare Company Inc (ACHC) Upgraded by BidaskClub to Hold
www.americanbankingnews.com - June 10 at 11:12 PM |
| Comparing Acadia Healthcare Company (ACHC) & Envision Healthcare Corp (AMSG)
www.americanbankingnews.com - June 10 at 10:52 PM |
| Acadia Healthcare Company Inc (ACHC) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - June 9 at 7:57 AM |
| Ensign Group (ENSG) Continues to Grow on Inorganic Path - Nasdaq
www.nasdaq.com - June 7 at 1:27 AM |
| State approves for-profit firm’s new hospital in partnership with University of Miami
finance.yahoo.com - June 5 at 6:16 PM |
| Acadia Healthcare Co., Inc. breached its 50 day moving average in a Bullish Manner : ACHC-US : June 2, 2017
finance.yahoo.com - June 2 at 3:40 PM |
| Q2 2017 EPS Estimates for Acadia Healthcare Company Inc (ACHC) Boosted by Jefferies Group
www.americanbankingnews.com - June 2 at 7:18 AM |
| Acadia Healthcare Company Inc (ACHC) Rating Reiterated by KeyCorp
www.americanbankingnews.com - June 1 at 5:32 PM |
| Acadia Healthcare to Participate in Jefferies 2017 Global Healthcare Conference
finance.yahoo.com - June 1 at 3:21 PM |
| Acadia Healthcare Company Inc (ACHC) Expected to Announce Quarterly Sales of $714.76 Million
www.americanbankingnews.com - May 31 at 11:32 AM |
| Zacks: Brokerages Anticipate Acadia Healthcare Company Inc (ACHC) to Announce $0.65 EPS
www.americanbankingnews.com - May 29 at 8:44 PM |
| Acadia Healthcare Company Breaks Below 200-Day Moving Average - Notable for ACHC
www.nasdaq.com - May 24 at 3:16 PM |
| Acadia Healthcare Co., Inc. breached its 50 day moving average in a Bearish Manner : ACHC-US : May 18, 2017
finance.yahoo.com - May 18 at 12:34 PM |
| Acadia Healthcare Company Inc (ACHC) Cut to Market Perform at Leerink Swann
www.americanbankingnews.com - May 15 at 10:16 AM |
| Acadia Healthcare Company Inc (ACHC) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - May 15 at 10:00 AM |
| ETFs with exposure to Acadia Healthcare Co., Inc. : May 11, 2017
finance.yahoo.com - May 11 at 8:28 PM |
| Acadia Healthcare Announces Additional Expected Interest Expense Savings with Latest Debt Repricing
finance.yahoo.com - May 10 at 3:24 PM |
| Randall P. Goldberg Sells 4,925 Shares of Acadia Healthcare Company Inc (ACHC) Stock
www.americanbankingnews.com - May 5 at 8:36 PM |
| Acadia Healthcare Company's (ACHC) "Buy" Rating Reaffirmed at Jefferies Group LLC
www.americanbankingnews.com - May 5 at 12:14 PM |
| Acadia Healthcare Company Inc (ACHC) Expected to Announce Earnings of $0.65 Per Share
www.americanbankingnews.com - May 4 at 8:14 AM |
| Insider Selling: Acadia Healthcare Company Inc (ACHC) COO Sells 86,483 Shares of Stock
www.americanbankingnews.com - May 3 at 9:58 PM |
 | Specialized Health Services Stocks on Investors' Radar -- DaVita, Acadia Healthcare, HealthSouth, - PR Newswire (press release)
www.prnewswire.com - May 3 at 3:20 PM |
| Acadia Healthcare Company (ACHC) Receiving Somewhat Positive Press Coverage, Analysis Shows
www.americanbankingnews.com - May 2 at 7:50 AM |
| ETFs with exposure to Acadia Healthcare Co., Inc. : May 1, 2017
finance.yahoo.com - May 2 at 5:40 AM |
| Acadia Healthcare Company Inc (ACHC) Upgraded to Hold at Zacks Investment Research
www.americanbankingnews.com - April 29 at 2:03 PM |
Acadia Healthcare Company (ACHC) Chart for Wednesday, July, 26, 2017
